약제 용출 스텐트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global drug-eluting stents market size is expected to reach USD 17.69 Billion in 2034 from USD 9.33 Billion in 2025, growing at a CAGR of 7.37 during 2026-2034.This market is witnessing strong growth due to increasing prevalence of cardiovascular diseases and rising demand for minimally invasive treatment procedures. Drug eluting stents are widely used to prevent artery blockage and reduce restenosis after angioplasty procedures. Growing aging populations, unhealthy lifestyles, and increasing incidence of coronary artery disease are significantly driving product demand. Technological advancements in stent coatings and biodegradable materials are also contributing to market expansion globally.

Increasing healthcare awareness and improved access to advanced cardiac treatments are major drivers supporting market growth. Hospitals and healthcare providers are increasingly adopting drug eluting stents because they improve patient outcomes and reduce repeat surgical interventions. Rising investments in cardiovascular research and development are further accelerating innovation in stent technologies. In addition, supportive reimbursement policies and expansion of healthcare infrastructure in developing regions are positively influencing market adoption.

Future prospects for the market remain highly favorable due to ongoing advancements in bioresorbable stents and precision cardiovascular therapies. Increasing focus on personalized treatment approaches and minimally invasive surgical solutions will continue creating growth opportunities. Emerging economies are expected to witness substantial demand growth due to rising healthcare expenditure and improving cardiac care services. As cardiovascular disease prevalence continues increasing worldwide, the market is projected to maintain steady long-term expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Coating Type

• Durable Polymer-based
• Bioresorbable Polymer-based
• Polymer-free

By Material

• CobaltChromium Alloy
• PlatinumChromium Alloy
• Stainless Steel
• Nitinol
• Magnesium Alloy / Composite

By Drug Type

• Sirolimus & Analogues (Everolimus, Zotarolimus, Biolimus A9)
• Paclitaxel
• Dual-therapy / Combination-drug Stents

By Application

• Coronary Artery Disease
• Peripheral Artery Disease

By End User

• Hospitals
• Cardiac Catheterization / PCI Centers
• Ambulatory Surgical Centers

COMPANIES PROFILED

• Abbott Laboratories, Alvimedica, B. Braun Melsungen AG, Balton Sp.z.o.o, Biosensors International Group Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical Inc., Elixir Medical Corporation, Johnson & Johnson Services LLC, JW Medical Systems, Lepu Medical Technology Co. Ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG ELUTING STENTS MARKET: BY COATING TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Coating Type
• 4.2. Durable Polymer-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bioresorbable Polymer-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Polymer-free Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG ELUTING STENTS MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Cobalt-Chromium Alloy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Platinum-Chromium Alloy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Stainless Steel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nitinol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Magnesium Alloy / Composite Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG ELUTING STENTS MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Drug Type
• 6.2. Sirolimus & Analogues (Everolimus, Zotarolimus, Biolimus A9) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Paclitaxel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Dual-therapy / Combination-drug Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG ELUTING STENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Coronary Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Peripheral Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DRUG ELUTING STENTS MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Cardiac Catheterization / PCI Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DRUG ELUTING STENTS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Coating Type
  • 9.2.2 By Material
  • 9.2.3 By Drug Type
  • 9.2.4 By Application
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Coating Type
  • 9.3.2 By Material
  • 9.3.3 By Drug Type
  • 9.3.4 By Application
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Coating Type
  • 9.4.2 By Material
  • 9.4.3 By Drug Type
  • 9.4.4 By Application
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Coating Type
  • 9.5.2 By Material
  • 9.5.3 By Drug Type
  • 9.5.4 By Application
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Coating Type
  • 9.6.2 By Material
  • 9.6.3 By Drug Type
  • 9.6.4 By Application
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DRUG ELUTING STENTS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 Alvimedica
  • 11.2.3 B. Braun Melsungen AG
  • 11.2.4 Balton Sp.z.o.o
  • 11.2.5 Biosensors International Group Ltd
  • 11.2.6 Biotronik SE & Co. KG
  • 11.2.7 Boston Scientific Corporation
  • 11.2.8 Cook Medical Inc
  • 11.2.9 Elixir Medical Corporation
  • 11.2.10 Johnson & Johnson Services LLC
  • 11.2.11 JW Medical Systems
  • 11.2.12 Lepu Medical Technology Co. Ltd
  • 11.2.13 Medtronic Plc
  • 11.2.14 Meril Life Sciences Pvt. Ltd
  • 11.2.15 MicroPort Scientific Corporation